The healthcare sector presents an opportunity for investors to acquire undervalued companies. The Relative Strength Index (RSI), a momentum indicator, helps traders assess a stock’s short-term performance potential. Oversold stocks have an RSI below 30, and here are a few major players in the healthcare sector that currently fit this criterion:
MultiPlan Corporation (MPLN)
* Released its first-quarter 2024 financial results on May 8, 2024.
* Stock fell around 18% over the past five days and reached a 52-week low of $0.55.
* RSI Value: 28.54
Agenus Inc. (AGEN)
* Announced updated results from its Phase 1 clinical trial of botensilimab and balstilimab for metastatic colorectal cancer.
* Stock fell around 48% over the past month and hit a 52-week low of $4.78.
* RSI Value: 28.59
These stocks may be attractive to investors seeking undervalued opportunities in the healthcare sector.
